Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital — Baltimore, Maryland

Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital has participated in 1 clinical trials.

Therapeutic areas: Healthy, Parkinson Disease.

Sponsors: H. Lundbeck A/S.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital?

Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital conducted?

Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital has 1 clinical trials on record. Their work covers Healthy, Parkinson Disease.

Is Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital accredited by Crixeo Health?

Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parexel, Early Phase Clinical Unit (EPCU), Harbor Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.